hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

Conditions:   Breast Cancer;   Lung Cancer;   Pancreatic Cancer;   Head and Neck Cancer;   Ovarian Cancer;   ColoRectal Cancer;   Gastric Cancer;   Esophageal Cancer;   HepatoCellular Carcinoma
Interventions:   Biological: INO-1400;   Biological: INO-9012
Sponsors:   Inovio Pharmaceuticals;   University of Pennsylvania;   University of North Carolina;   Thomas Jefferson University;   University of Pittsburgh;   Wayne State University;   Mayo Clinic
Recruiting - verified November 2016

https://clinicaltrials.gov/ct2/show/NCT02960594?term=HEAD+AND+NECK&recr=Open&lup_s=10%2F26%2F2016&lup_d=14&show_rss=Y&sel_rss=mod14